Log in
NASDAQ:ITCI

Intra-Cellular Therapies SEC Filings & 10K Form

$30.97
+0.24 (+0.78 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
$30.26
Now: $30.97
$31.98
50-Day Range
$17.61
MA: $20.86
$31.86
52-Week Range
$6.75
Now: $30.97
$43.56
Volume1.36 million shs
Average Volume1.37 million shs
Market Capitalization$2.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.68

SEC Filings

Intra-Cellular Therapies (NASDAQ:ITCI) SEC Filings

DateFilerForm TypeView
09/14/2020
4:03 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
6:08 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
3:47 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
3:44 PM
Intra-Cellular Therapies (Filer)
Form 424B5
09/11/2020
3:15 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
3:02 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
4:26 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:40 PM
Intra-Cellular Therapies (Filer)
Form 424B5
09/09/2020
6:13 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:16 PM
Intra-Cellular Therapies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2020
7:17 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:52 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
4:48 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:12 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:05 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:02 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
5:58 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:14 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
8:17 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
8:07 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:17 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:13 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:09 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:06 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:03 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
3:16 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
4:37 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
6:48 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:20 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
3:31 PM
Intra-Cellular Therapies (Filer)
Form DEFA14A
05/07/2020
6:42 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
6:32 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/02/2020
5:05 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
5:01 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
4:55 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
4:50 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
6:52 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
7:02 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/02/2020
6:43 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
6:42 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:39 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:35 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:30 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:27 PM
Intra-Cellular Therapies (Issuer)
Satlin Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
10:01 AM
Intra-Cellular Therapies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2020
1:29 PM
BB BIOTECH AG (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G
02/05/2020
10:46 AM
BlackRock Inc. (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
01/28/2020
8:31 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
8:30 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
8:28 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
5:13 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:14 PM
Intra-Cellular Therapies (Issuer)
Satlin Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:11 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:09 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:06 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:03 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:11 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:02 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:00 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
4:12 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
4:06 PM
Intra-Cellular Therapies (Filer)
Form 424B5
01/03/2020
8:17 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:16 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:14 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:13 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:12 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:11 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:06 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
7:15 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
7:17 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:40 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
3:50 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:37 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:35 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:32 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:29 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
4:11 PM
ALAFI CAPITAL CO LLC (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13D/A
09/12/2019
11:15 PM
Intra-Cellular Therapies (Filer)
Form EFFECT
09/12/2019
4:06 PM
Intra-Cellular Therapies (Filer)
Form 424B3
09/12/2019
4:02 PM
Intra-Cellular Therapies (Filer)
Form 424B3
09/11/2019
3:30 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
5:24 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
7:24 PM
Intra-Cellular Therapies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/07/2019
3:16 PM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
7:08 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
5:07 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
6:10 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
8:17 AM
Intra-Cellular Therapies (Filer)
Form CT ORDER
07/02/2019
4:17 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:12 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:48 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:47 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:45 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:43 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:33 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:31 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
4:50 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
4:48 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.